Compugen (CGEN) Non Operating Interest Expenses (2011 - 2012)
Compugen (CGEN) posted quarterly Non Operating Interest Expenses of -$1.5 million for Q4 2012, down 15.8% year-over-year from -$1.8 million in Q1 2012, and down 15.8% on a QoQ basis from -$1.3 million in Q4 2011.
Compugen (CGEN) Non Operating Interest Expenses (2011 - 2012) Analysis & Trends
Compugen has reported Non Operating Interest Expenses for 2 years, with the latest figure at -$1.5 million in Q4 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Compugen | 227.88 Mn | 136.13 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | -1.53 Mn |
| Dec 31, 2011 | -1.32 Mn |